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Dissecting Human Dicer: Some Assembly RequiredGene silencing by diverse noncoding RNAs, in-
cluding microRNAs (miRNAs) and small interfering
RNAs (siRNAs), is an integral aspect of eukaryotic
gene regulation, host defense, and genome surveil-
lance. miRNAs and siRNAs bind to speciﬁc mRNAs
through complementary base pairing, leading to
translation inhibition and accelerated RNA decay.
Noncoding RNAs also direct heterochromatin forma-
tion in a sequence-speciﬁc manner, causing selective
transcriptional silencing.1,2 The dynamic response of
gene expression to changes in cellular state is a
function of qualitative and quantitative changes in the
miRNA and (endo)siRNA populations.3,4 While
transcriptional control mechanisms are of key impor-
tance, much attention also is being paid on the
ribonucleases that establish thematuration pathways,
and how the RNAs are accurately generated from
precursors in a regulated manner.
The RNase III family enzyme Dicer precisely
cleaves the immediate precursors of miRNAs and
siRNAs to directly provide the mature forms.5,6
Dicer works in association with other proteins, such
as the mammalian double‐stranded RNA (dsRNA)-
binding proteins TRBP and PACT.7 However, it is
now evident, through recent studies summarized
below, that Dicer is inherently quite capable of the
selective recognition and accurate processing of
structurally diverse precursors. The molecular tal-
ents of Dicer reﬂect the speciﬁc interactions of the
multiple domains of the polypeptide. The dsRNA-
speciﬁc RNase III domain—the core catalytic ele-
ment and deﬁning feature of RNase III family
members—is created through intramolecular asso-
ciation of tandem domains (RIIIa, RIIIb), forming a
pseudodimeric structure that contains the catalytic
center. On the N-terminal side is the PAZ domain
that selectively recognizes the 2‐nt, 3′-overhang
structures, created by the prior action of Dicer on
dsRNA, or of Drosha (another RNase III family
member) on pri-miRNAs. A domain of unknown
function (DUF283) is followed by an ATPase/heli-
case (ATP/hel) domain that also is the N-terminal
structure. On the C-terminal side of the RNase III
domain, and completing the ~230‐kDa polypeptide,
is a dsRNA-binding domain (dsRBD)—a conserved0022-2836 © 2012 Elsevier Ltd. Open access under CC BY-NC-ND licefold present in most RNase III family members and
in many other dsRNA-binding proteins.
Fundamental aspects of miRNA and siRNA
processing have been productively analyzed using
Dicer from diverse organisms. Dicer of Giardia
intestinalis, composed of the PAZ–IIIa–IIIb triumvi-
rate, yielded the ﬁrst structural insight on how
siRNA length is established through cooperation of
the PAZ and RNase III domains.8 Establishing a
high-resolution structure–function proﬁle of Human
Dicer (hDcr) has been of particular interest, partic-
ularly with respect to human health, given the
altered miRNA proﬁles of cancer cells3 and that
hDcr haploinsufﬁciency or speciﬁc mutation also is
implicated in certain cancers.9,10 However, hDcr has
been a continuing challenge for structural and
biochemical analyses, as it is particularly refractory
towards puriﬁcation in the needed amounts.
Doudna et al. have provided a major step forward
in our understanding of hDcr by separately expres-
sing the domains in bacterial cells, and then testing
the domains individually and in combination for
catalytic activity and other behaviors.11 Through
this approach, new light has been shed on several
enigmatic yet key structural features. First, limited
proteolytic cleavage was used to identify bound-
aries of domains that then were separately
expressed in and puriﬁed from bacterial cells. The
RNase III domain with attached dsRBD was active,
but produced 15‐bp dsRNAs rather than the normal
22‐bp products. While this behavior is reminiscent
of bacterial RNase III action, inclusion of the
puriﬁed DUF-PAZ domain re-established the char-
acteristic 22-bp product length, providing biochem-
ical conﬁrmation of the crystallographic evidence8
that the PAZ and RNase III domains together
provide the sizing mechanism.
The dsRBD posed continuing questions as to its
function, since the domain is not strictly conserved,
and that its selective removal does not strongly
affect hDcr activity in vitro.12 However, Doudna et
al. showed that the dsRBD is required for substrate
binding and cleavage in the absence of the PAZ
domain.11 This ﬁnding, along with the previous
demonstration of the functional requirement for thense.
465Dissecting Human Dicer: Some Assembly RequireddsRBD of an engineered (intermolecular) dimeric
form of the hDcr RNase IIIb domain,13 shows that
the hDcr dsRBD is functional in RNA recognition,
although it cannot replace the PAZ domain in
providing correctly sized products. With the ques-
tion of inherent functionality of the hDcr dsRBD
answered, the focus now can shift to identifying
substrates that are processed by hDcr in a dsRBD-
dependent manner.
The N-terminal ATP/hel domain also is slow to
reveal its functions. The ATP/hel domain has an
inhibitory effect on the processing of siRNA pre-
cursors, in that its removal allowed cleavage of pre-
siRNAs with comparable efﬁciency as seen with
pre-miRNAs.14 Using a bacterially expressed fusion
protein, it was shown that the ATP/hel domain
preferentially recognizes the loop structures of pre-
miRNA.11 The authors propose a “gatekeeper”
function in conferring regulated access of RNA to
the catalytic portion of hDcr. An interaction of
TRBP with this domain11 also supports a regulated
access mechanism. Having a domain with a
gatekeeper function is perhaps not unexpected, as
ribonucleases operate in RNA-rich environments,
and an otherwise uncontrolled access of RNA to a
nuclease active site could be detrimental to the cell.
Ten years after the ﬁrst descriptions of the basic
biochemical behavior of recombinant hDcr,15,16 we
are now witnessing a convergence of experimental
approaches including, inter alia, electron microscopy
of modiﬁed hDcr17 and in vivo structure–function
analysis of hDcr mutants18 that reveals the struc-
tural basis for hDcr function. The ability to study
hDcr through reassembled domains largely circum-
vents the difﬁculties in working with full-length
protein and is expected to set the stage for
biochemical and high-resolution structural studies
on the protein–protein and RNA–protein interac-
tions that establish the regulated maturation of
mammalian miRNAs and siRNAs. In turn, an
understanding of the interactions of hDcr with
factors such as TRBP and PACT will allow full
appreciation of a dynamic cellular nexus of dsRNA-
dependent transactions that underlie mammalian
posttranscriptional regulation.References
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